Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 254.39M | 210.84M | 396.57M | 341.33M | 689.91M | 2.13B |
Gross Profit | 62.78M | -35.49M | -63.54M | 89.90M | 465.41M | 1.02B |
EBITDA | -139.33M | -651.93M | -871.38M | -130.08M | -417.54M | 624.10M |
Net Income | -739.99M | -590.69M | -932.05M | -966.29M | -928.11M | 37.45M |
Balance Sheet | ||||||
Total Assets | 13.28B | 12.24B | 14.16B | 15.83B | 19.07B | 21.52B |
Cash, Cash Equivalents and Short-Term Investments | 1.97B | 1.66B | 2.44B | 3.39B | 5.33B | 5.74B |
Total Debt | 1.50B | 2.91B | 3.87B | 4.26B | 5.46B | 7.15B |
Total Liabilities | 4.03B | 3.50B | 4.63B | 5.08B | 6.57B | 8.44B |
Stockholders Equity | 8.00B | 7.61B | 8.24B | 9.27B | 10.72B | 11.31B |
Cash Flow | ||||||
Free Cash Flow | -209.51M | -306.65M | -371.35M | -130.99M | -83.53M | -165.45M |
Operating Cash Flow | -287.83M | -305.76M | -371.11M | -126.34M | -81.15M | -150.47M |
Investing Cash Flow | 89.97M | 376.26M | -51.51M | -60.06M | 3.10B | 931.26M |
Financing Cash Flow | -748.17M | -984.91M | -422.79M | -1.62B | -1.85B | -101.01M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
65 Neutral | $2.03B | 16.82 | 4.04% | 5.06% | 2.46% | 2.10% | |
62 Neutral | HK$605.99M | ― | -10.79% | 6.21% | -4.53% | -22.06% | |
52 Neutral | HK$583.97M | ― | -3.95% | 7.39% | -1.13% | -79.58% | |
51 Neutral | HK$677.78M | ― | -1.19% | 3.45% | 111.64% | -282.42% | |
49 Neutral | HK$499.02M | ― | -2.14% | 0.94% | -7.37% | -456.37% | |
48 Neutral | HK$610.48M | ― | -8.17% | ― | -43.81% | 29.95% | |
43 Neutral | HK$525.60M | ― | -8.20% | ― | 8.54% | -54.48% |
Chuang’s Consortium International Limited has announced its upcoming annual general meeting, which will be held virtually on September 15, 2025. The meeting’s agenda includes the consideration of the company’s audited financial statements, the re-election and election of directors, and the re-appointment of PricewaterhouseCoopers as the auditor. Additionally, shareholders will vote on resolutions to authorize the board to repurchase shares and to allot and issue new shares, reflecting the company’s strategic focus on maintaining flexibility in its capital management.
Chuang’s Consortium International Limited has outlined the terms of reference for its Nomination Committee, which is responsible for overseeing the structure, size, composition, and diversity of the company’s board of directors. The committee’s duties include identifying qualified candidates for board membership, assessing the independence of non-executive directors, and supporting board performance evaluations. This initiative is aimed at ensuring that the board’s composition aligns with the company’s corporate strategy and policies, thereby enhancing its governance and operational effectiveness.
Chuang’s Consortium International Limited has announced the composition of its Board of Directors, highlighting the roles and functions of each member. The Board consists of both executive and independent non-executive directors, with Mr. Albert Chuang Ka Pun serving as Chairman and Managing Director. The announcement also details the establishment of four committees within the Board, specifying the membership and leadership roles of each director in these committees. This organizational structure is crucial for the company’s governance and strategic decision-making, potentially impacting its operational efficiency and stakeholder confidence.
Chuang’s Consortium International Limited announced its final results for the year ending March 31, 2025, highlighting significant property disposals and project developments. The company completed the sale of properties in Hong Kong, Mongolia, and Singapore, bolstering its financial position with substantial cash proceeds. The company also reported progress on various real estate projects, including the completion of construction and sales of residential units in Hong Kong. Financially, the group improved its net debt to equity ratio to 15.8% and reduced its loss attributable to equity holders by 36.6% to HK$590.7 million.
Chuang’s Consortium International has announced a very substantial disposal involving the sale of a share and loan, with an estimated consideration of up to HK$538.5 million. This transaction, subject to shareholder approval, is significant as it exceeds 75% of the applicable percentage ratio under the Listing Rules, indicating a major shift in the company’s asset portfolio. The controlling shareholder, EHL, has committed to supporting the transaction, ensuring a smooth approval process.
Chuang’s Consortium International Limited has announced that its board of directors will convene a meeting on June 27, 2025, to discuss and approve the final results for the fiscal year ending March 31, 2025, and to consider the recommendation of a dividend payment. This meeting is significant as it will determine the company’s financial performance and potential shareholder returns, impacting its market positioning and stakeholder interests.
Chuang’s Consortium International Limited has announced an expected reduction in its losses for the fiscal year ending March 31, 2025, with anticipated losses ranging between HK$580 million to HK$640 million, compared to a loss of HK$932 million in the previous year. This improvement is attributed to gains from the disposal of subsidiaries in Mongolia and Singapore, despite facing fair value losses and impairment provisions in its property investments. The company assures stakeholders that these losses are primarily accounting losses with no immediate cash flow impact, maintaining a healthy financial position.